{"id":12697,"date":"2024-10-22T06:00:00","date_gmt":"2024-10-21T21:00:00","guid":{"rendered":"https:\/\/korea.yozma.asia\/?p=12697"},"modified":"2024-10-28T11:20:27","modified_gmt":"2024-10-28T02:20:27","slug":"bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting","status":"publish","type":"post","link":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/","title":{"rendered":"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-1024x512.jpg\" alt=\"\" class=\"wp-image-12682 lazyload\"><noscript><img decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-1024x512.jpg\" alt=\"\" class=\"wp-image-12682\" srcset=\"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-1024x512.jpg 1024w, https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-300x150.jpg 300w, https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-768x384.jpg 768w, https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-1536x768.jpg 1536w, https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-1000x500.jpg 1000w, https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d-670x335.jpg 670w, https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg 1738w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/noscript><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">\ucd5c\uadfc \uc0c1\ub2f9\uc218 \uc81c\uc57d\ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc774 \uc2e4\uc801 \uc545\ud654\ub85c \uc778\ud574 \uac10\uc790\uc640 \uc720\uc0c1\uc99d\uc790 \ub4f1\uc744 \ud1b5\ud574 \uc7ac\ubb34\uad6c\uc870\ub97c \uac1c\uc120\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \uac00\uc6b4\ub370 \ub3d9\uc804\uc8fc\ub85c \uc804\ub77d\ud55c \ube44\uc5d8\ud31c\ud14d\uc774 \ud604\uc7ac \uc790\ubcf8\uc7a0\uc2dd \uc0c1\ud0dc\ub97c \ubc97\uc5b4\ub098\uace0\uc790 90% \uac10\uc790\ub97c \uacb0\uc815\ud574 \uc2dc\uc120\uc744 \ub04c\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube44\uc5d8\ud31c\ud14d\uc758 \ubb34\uc0c1 \uac10\uc790 \uacb0\uc815\uc774 \uc54c\ub824\uc9c0\uba74\uc11c \ud22c\uc2ec \uc545\ud654\ub85c \uc8fc\uac00\uac00 \uc57d\uc138\ub97c \ub4dc\ub7ec\ub0c8\uc9c0\ub9cc, \uc774\ubc88 \uac10\uc790\ub85c \ud68c\uc0ac\ub294 \uc790\ubcf8\uc7a0\uc2dd \uc0c1\ud0dc\uc5d0\uc11c \ubc97\uc5b4\ub098\uac8c \ub3fc \ub2f9\uc7a5\uc758 \uad00\ub9ac\uc885\ubaa9 \ub9ac\uc2a4\ud06c\ub294 \ud53c\ud558\uac8c \ub410\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ucd5c\uadfc \uc0c1\ub2f9\uc218 \uc81c\uc57d\ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc774 \uc2e4\uc801 \uc545\ud654\ub85c \uc778\ud574 \uac10\uc790\uc640 \uc720\uc0c1\uc99d\uc790 \ub4f1\uc744&#8230;<\/p>\n","protected":false},"author":2,"featured_media":12682,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[127],"tags":[452],"class_list":["post-12697","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news-en","tag-blpharmtech-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting - YOZMA GROUP KOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting - YOZMA GROUP KOREA\" \/>\n<meta property=\"og:description\" content=\"\ucd5c\uadfc \uc0c1\ub2f9\uc218 \uc81c\uc57d\ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc774 \uc2e4\uc801 \uc545\ud654\ub85c \uc778\ud574 \uac10\uc790\uc640 \uc720\uc0c1\uc99d\uc790 \ub4f1\uc744...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/\" \/>\n<meta property=\"og:site_name\" content=\"YOZMA GROUP KOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/yozmafund\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-21T21:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-28T02:20:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1738\" \/>\n\t<meta property=\"og:image:height\" content=\"869\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"yozmakorea\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@YozmaGroupKorea\" \/>\n<meta name=\"twitter:site\" content=\"@YozmaGroupKorea\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"yozmakorea\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/\"},\"author\":{\"name\":\"yozmakorea\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#\\\/schema\\\/person\\\/c965e2157c4971b1e46632078c7aa514\"},\"headline\":\"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting\",\"datePublished\":\"2024-10-21T21:00:00+00:00\",\"dateModified\":\"2024-10-28T02:20:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/\"},\"wordCount\":14,\"publisher\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/korea.yozma.asia\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg\",\"keywords\":[\"BLPharmtech\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/\",\"url\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/\",\"name\":\"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting - YOZMA GROUP KOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/korea.yozma.asia\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg\",\"datePublished\":\"2024-10-21T21:00:00+00:00\",\"dateModified\":\"2024-10-28T02:20:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/korea.yozma.asia\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg\",\"contentUrl\":\"https:\\\/\\\/korea.yozma.asia\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg\",\"width\":1738,\"height\":869},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#website\",\"url\":\"https:\\\/\\\/korea.yozma.asia\\\/\",\"name\":\"YOZMA GROUP KOREA\",\"description\":\"Yozma Group Korea Co., Ltd\",\"publisher\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#organization\"},\"alternateName\":\"Yozma Group Korea\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/korea.yozma.asia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#organization\",\"name\":\"Yozma Group Korea\",\"alternateName\":\"Yozma Group Korea\",\"url\":\"https:\\\/\\\/korea.yozma.asia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/korea.yozma.asia\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Yozma_logo_symbol.png\",\"contentUrl\":\"https:\\\/\\\/korea.yozma.asia\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Yozma_logo_symbol.png\",\"width\":500,\"height\":495,\"caption\":\"Yozma Group Korea\"},\"image\":{\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/yozmafund\",\"https:\\\/\\\/x.com\\\/YozmaGroupKorea\",\"https:\\\/\\\/linkedin.com\\\/company\\\/theyozmagroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/korea.yozma.asia\\\/#\\\/schema\\\/person\\\/c965e2157c4971b1e46632078c7aa514\",\"name\":\"yozmakorea\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9a90287798de63e9ba840e33078cdabfcf9284296770605b57d4992c798171aa?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9a90287798de63e9ba840e33078cdabfcf9284296770605b57d4992c798171aa?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9a90287798de63e9ba840e33078cdabfcf9284296770605b57d4992c798171aa?s=96&d=mm&r=g\",\"caption\":\"yozmakorea\"},\"sameAs\":[\"https:\\\/\\\/korea.yozma.asia\"],\"url\":\"https:\\\/\\\/korea.yozma.asia\\\/en\\\/author\\\/yozmakorea\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting - YOZMA GROUP KOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/","og_locale":"en_US","og_type":"article","og_title":"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting - YOZMA GROUP KOREA","og_description":"\ucd5c\uadfc \uc0c1\ub2f9\uc218 \uc81c\uc57d\ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc774 \uc2e4\uc801 \uc545\ud654\ub85c \uc778\ud574 \uac10\uc790\uc640 \uc720\uc0c1\uc99d\uc790 \ub4f1\uc744...","og_url":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/","og_site_name":"YOZMA GROUP KOREA","article_publisher":"https:\/\/www.facebook.com\/yozmafund","article_published_time":"2024-10-21T21:00:00+00:00","article_modified_time":"2024-10-28T02:20:27+00:00","og_image":[{"width":1738,"height":869,"url":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg","type":"image\/jpeg"}],"author":"yozmakorea","twitter_card":"summary_large_image","twitter_creator":"@YozmaGroupKorea","twitter_site":"@YozmaGroupKorea","twitter_misc":{"Written by":"yozmakorea","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#article","isPartOf":{"@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/"},"author":{"name":"yozmakorea","@id":"https:\/\/korea.yozma.asia\/#\/schema\/person\/c965e2157c4971b1e46632078c7aa514"},"headline":"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting","datePublished":"2024-10-21T21:00:00+00:00","dateModified":"2024-10-28T02:20:27+00:00","mainEntityOfPage":{"@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/"},"wordCount":14,"publisher":{"@id":"https:\/\/korea.yozma.asia\/#organization"},"image":{"@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#primaryimage"},"thumbnailUrl":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg","keywords":["BLPharmtech"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/","url":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/","name":"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting - YOZMA GROUP KOREA","isPartOf":{"@id":"https:\/\/korea.yozma.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#primaryimage"},"image":{"@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#primaryimage"},"thumbnailUrl":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg","datePublished":"2024-10-21T21:00:00+00:00","dateModified":"2024-10-28T02:20:27+00:00","breadcrumb":{"@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#primaryimage","url":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg","contentUrl":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/10\/\ub274\uc2a4\ub808\ud130\uc378\ub124\uc77c_0030_\ube44\uc5d8\ud31c\ud14d.jpg","width":1738,"height":869},{"@type":"BreadcrumbList","@id":"https:\/\/korea.yozma.asia\/en\/bl-pharmtech-decides-on-10-to-1-reverse-stock-split-aiming-to-reduce-risk-of-delisting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/korea.yozma.asia\/en\/"},{"@type":"ListItem","position":2,"name":"BL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting"}]},{"@type":"WebSite","@id":"https:\/\/korea.yozma.asia\/#website","url":"https:\/\/korea.yozma.asia\/","name":"YOZMA GROUP KOREA","description":"Yozma Group Korea Co., Ltd","publisher":{"@id":"https:\/\/korea.yozma.asia\/#organization"},"alternateName":"Yozma Group Korea","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/korea.yozma.asia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/korea.yozma.asia\/#organization","name":"Yozma Group Korea","alternateName":"Yozma Group Korea","url":"https:\/\/korea.yozma.asia\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/korea.yozma.asia\/#\/schema\/logo\/image\/","url":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/02\/Yozma_logo_symbol.png","contentUrl":"https:\/\/korea.yozma.asia\/wp-content\/uploads\/2024\/02\/Yozma_logo_symbol.png","width":500,"height":495,"caption":"Yozma Group Korea"},"image":{"@id":"https:\/\/korea.yozma.asia\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/yozmafund","https:\/\/x.com\/YozmaGroupKorea","https:\/\/linkedin.com\/company\/theyozmagroup"]},{"@type":"Person","@id":"https:\/\/korea.yozma.asia\/#\/schema\/person\/c965e2157c4971b1e46632078c7aa514","name":"yozmakorea","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9a90287798de63e9ba840e33078cdabfcf9284296770605b57d4992c798171aa?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9a90287798de63e9ba840e33078cdabfcf9284296770605b57d4992c798171aa?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9a90287798de63e9ba840e33078cdabfcf9284296770605b57d4992c798171aa?s=96&d=mm&r=g","caption":"yozmakorea"},"sameAs":["https:\/\/korea.yozma.asia"],"url":"https:\/\/korea.yozma.asia\/en\/author\/yozmakorea\/"}]}},"_links":{"self":[{"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/posts\/12697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/comments?post=12697"}],"version-history":[{"count":1,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/posts\/12697\/revisions"}],"predecessor-version":[{"id":12698,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/posts\/12697\/revisions\/12698"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/media\/12682"}],"wp:attachment":[{"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/media?parent=12697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/categories?post=12697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/korea.yozma.asia\/en\/wp-json\/wp\/v2\/tags?post=12697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}